Association of Remnant Cholesterol Inflammation Index with Cardiovascular Risks and All-Cause Mortality in

Qi-Lin Ma1, Lei-Lei Du2, Jia Peng1

  • 1Department of Cardiovascular Medicine, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

PubMed

Insights

The Remnant Cholesterol Inflammation Index (RCII) predicts mortality and cardiovascular disease (CVD) risk in diabetes and prediabetes. This index combines remnant cholesterol and inflammation, aiding early identification of high-risk individuals.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Biomarker Discovery

Background:

  • Remnant cholesterol (RC) and low-grade inflammation are known cardiovascular disease (CVD) risk factors in diabetes.
  • The combined prognostic impact of RC and inflammation in dysglycemia is not well understood.
  • This study investigates the Remnant Cholesterol Inflammation Index (RCII) for risk prediction in diabetes/prediabetes.

Purpose of the Study:

  • To evaluate the Remnant Cholesterol Inflammation Index (RCII) as a predictor of all-cause mortality and CVD risk.
  • To assess the synergistic effect of remnant cholesterol and hsCRP in individuals with diabetes or prediabetes.
  • To identify a novel biomarker for early risk stratification in dysglycemic populations.

Main Methods:

  • Utilized data from 2206 US adults with diabetes/prediabetes (NHANES 2015-2018).
  • Calculated RCII as [RC (mg/dL) × hsCRP (mg/L)]/10.
  • Employed Cox and logistic regression for mortality and CVD risk prediction, respectively.

Main Results:

  • Higher RCII quartiles showed graded associations with all-cause mortality (HR 2.45 for Q4 vs. Q1).
  • Significant dose-dependent relationships were observed for CVD risk and mortality.
  • Subgroup analyses indicated consistent mortality associations and sex-specific CVD interactions.

Conclusions:

  • The RCII serves as a valuable biomarker for predicting all-cause mortality and CVD risks in individuals with diabetes or prediabetes.
  • The index highlights the combined impact of remnant cholesterol and inflammation on adverse outcomes.
  • RCII may facilitate early identification of high-risk individuals for targeted interventions.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Inflammation01:38

Inflammation

Overview
61.7K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
923